Celsis
www.celsis.comSymbol: CEL.L
Currently trading at: 232.17p DOWN 0.33
Celsis International is a world-leading microbial detection and analytical services company operating through two divisions, the Product Group and the Laboratory Group.
Using its proprietary enzyme technology, the Product Group is the world leader in the provision of diagnostic systems for the rapid detection of microbial contamination. It works in close collaboration with many of the world's leading pharmaceutical, personal care and beverage companies, ensuring the safety and quality of products bound for consumers.
The Laboratory Group provides outsourced analytical testing services to pharmaceutical and biopharma companies to ensure the stability and chemical composition of their products.
Celsis was formed in 1992 when Enzymatix was separated into three individual companies by its founder, biotech entrepreneur Professor Sir Christopher Evans OBE who had formed the parent company just five years earlier.
In early August 2009, Celsis received and recommended an offer of £54.5m from North Atlantic Value LLP
Staff
 Jay LeCoque, Chief Executive OfficerMr LeCoque, an American, age 42, has served as a Board member and Chief Executive Officer since November 2000. Mr LeCoque joined Celsis in April 1995 as a Director of Business Development. He then progressed to Vice President of Sales and Marketing for the Americas and finally became the General Manager of Celsis, Inc., the Americas profit centre where he helped Celsis International plc deliver its first year of profitability in 1999. Mr LeCoque came to Celsis from Baxter International Corporation, a leading global healthcare company, where he served in various global marketing and product management positions from 1991 to April of 1995. Mr LeCoque worked for the AptarGroup, a leading supplier of pharmaceutical and personal care dispensing and drug delivery systems from 1985 to 1989 where he held various sales and marketing positions in the US, England and France. Mr LeCoque received his MBA from the Kellogg Graduate School of Management at Northwestern University in Evanston, Illinois in 1991 and his BS in Marketing and General Management from Miami University in Oxford, Ohio in 1985, both in the United States. |  Christian Madrolle, Finance DirectorMr Madrolle, a Frenchman, age 59, has served as a Board member and Finance Director since October 2000. Mr Madrolle came to Celsis from Biocom, a French biotech company specialising in filter cytometry and scientific imaging systems, where he served as Vice President, Finance and later President and Chief Executive. Prior to this Mr Madrolle worked for the Portakabin Group, the modular building solutions company, as Director and General Manager of the European Division, developing and creating profitable subsidiaries across Europe. Mr Madrolle worked for Transport International Pool Inc, part of the GE Capital Group, in Amsterdam before this, where he was Managing Director for southern Europe. Mr Madrolle was previously General Manager of Portakabin, in France, prior to this he started his career with Xerox, as Finance and Administration Manager. Mr Madrolle received a BSc in Accounting & Finance, from the University of Paris-XII, in 1973 and completed a MSc in Financial Management at IFG, Paris, in 1974. He is also a member of the OECB (Order of Belgium Chartered Accountants). |
Contact details
Kings Court
Newmarket
Suffolk, CB8 7SG
Tel: 01638 600 151
Fax: 01638 600 160
